23.11.2016 • NewsElaine Burridgefeedstockfertilizer

OCP and Ethiopia in $3.7 Billion Fertilizer Project

Leading phosphate exporter Office Cherifien des Phosphates (OCP) has signed an agreement with the Ethiopian Ministry of Public Enterprise to build a $3.7 billion fertilizer plant in the east African country. OCP, which is 95% owned by the Moroccan government, said the "game-changing partnership" is based on a common vision between Morocco and Ethiopia for sustainable agricultural development across Africa and reinforces economic ties between the two countries.

The first phase of the project will see $2.4 billion invested in a plant in Dire Dawa, 250 kilometers east of the capital Addis Ababa, to produce 2.5 million t/y of fertilizer. Start-up is slated for mid-2022. Part of the investment will also be spent on developing infrastructure at Djibouti harbor to handle the phosphoric acid imported from OCP in Morocco. Potash and ammonia feedstocks will be sourced from Ethiopia.

OCP said 60% of the first-phase investment will come from debt financing with the rest in equal shares from the two partners. A second-phase investment of $1.3 billion will be made to raise capacity to 3.8 million t/y by 2025. The plant’s output is expected to more than meet all of Ethiopia's fertilizer demand with the excess being exported, aided by a new railway line that will connect the plant to neighboring countries.

Ethiopia's agricultural sector is said to account for 45% of the country's GDP and 90% of its exports. According to the World Bank, Ethiopia is the second most populous country in Sub-Saharan Africa with GDP growth of 9.6% in 2015. 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.